SCHEMBL7576137

SCHEMBL7576137

COc1ccc(-c2ccc[c]c2F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.49
ABCB1 P08183 1/20 0.49
BCR P11274 1/20 0.49
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
PTGS2 P35354 1/20 0.42
STAT3 P40763 1/20 0.40
BACE1 P56817 3/20 0.40
NPC1 O15118 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17514701 0.84 ABL1 (0.51) ABL1ABCB1BCRPTGS2TP53
SCHEMBL2588281 0.81 KDM1A (0.44) HDAC4HDAC8CLK4
SCHEMBL3320235 0.81 KMT2A (0.40) SYK
SCHEMBL1867724 0.80 ABL1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL4561266 0.80 ABL1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL1646811 0.80 ABL1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL1646823 0.80 ABL1 (0.50) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL7805516 0.79 PTGS2 (0.36) PTGS2NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL9788256 0.79 PTGS2 (0.40) ABL1PTGS2NPC1MAPTRAB9A
SCHEMBL1644865 0.79 ABL1 (0.49) ABL1ABCB1BCRHDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002089799-A2 USE OF DIHYDROPYRAZOLES TO INCREASE ERYTHROPOIETIN AND VASCULARI ZATION THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO claimed
US-5798340-A ANTITUMOR/ANTINEOPLASTIC ACTIITY, VIRICIDES; BROAD SPECTRUM MICROBIOCIDES; THIOPHOSPHONATES HYDROLYZABLE IN VIVO; ORAL ADMINISTRATION; BIOAVAILABILITY; NONTOXIC; POTENCY GILEAD SCIENCES, INC. (US) 1998-08-25 US claimed